Skip to main content

Table 2 Mean/median QoL scores at baseline, month 3 and month 6 visits

From: Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study

QoL summary score Baseline visit Month 3 visit Month 6 visit Change from baseline to month 6 (SD/correlation) p value
Mean (SD) or median (IQR) Mean (SD) or median (IQR) Mean (SD) or median (IQR)
PHS 46.5 (4.6) 47.1 (3.9) 47.3 (3.8) 0.8 (5.0)
p = 0.0036
MHS 46.4 (4.5) 47.4 (3.5) 47.2 (3.3) 0.8 (4.8)
p = 0.0002
GPGI 71.7 (55, 85) 71.67 (57, 85) 73.3 (60,87) r = 0.35
p < 0.001